These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

371 related articles for article (PubMed ID: 12016492)

  • 41. Botulinum toxin: examining duration of effect in facial aesthetic applications.
    Flynn TC
    Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Botulinum toxin type A for upper limb spasticity following stroke: an open-label study with individualised, flexible injection regimens.
    Slawek J; Bogucki A; Reclawowicz D
    Neurol Sci; 2005 Apr; 26(1):32-9. PubMed ID: 15877185
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Evaluating effects of preservative-containing saline solution on pain perception during botulinum toxin type-a injections at different locations: a prospective, single-blinded, randomized controlled trial.
    Sarifakioglu N; Sarifakioglu E
    Aesthetic Plast Surg; 2005; 29(2):113-5. PubMed ID: 15815811
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Comparison between intramuscular and perimuscular injections of botulinum toxin type A.
    Campos JH; Oliveira LB; Queiroz TO; Santos KP; Freitas FM
    Aesthetic Plast Surg; 2006; 30(6):700-3; discussion 704. PubMed ID: 16977369
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Management of the ageing eyebrow and forehead: an objective dose-response study with botulinum toxin.
    Levy JL; Pons F; Jouve E
    J Eur Acad Dermatol Venereol; 2006 Jul; 20(6):711-6. PubMed ID: 16836501
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Reduction of salivary flow with botulinum toxin: extended report on 33 patients with drooling, salivary fistulas, and sialadenitis.
    Ellies M; Gottstein U; Rohrbach-Volland S; Arglebe C; Laskawi R
    Laryngoscope; 2004 Oct; 114(10):1856-60. PubMed ID: 15454785
    [TBL] [Abstract][Full Text] [Related]  

  • 47. An overview of the cosmetic treatment of facial muscles with a new botulinum toxin.
    Wiest LG
    Acta Dermatovenerol Croat; 2009; 17(1):48-53. PubMed ID: 19386215
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Botulinum toxin type A as migraine preventive treatment in patients previously failing oral prophylactic treatment due to compliance issues.
    Cady R; Schreiber C
    Headache; 2008 Jun; 48(6):900-13. PubMed ID: 18047501
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Contraindications and complications with the use of botulinum toxin.
    Klein AW
    Clin Dermatol; 2004; 22(1):66-75. PubMed ID: 15158548
    [TBL] [Abstract][Full Text] [Related]  

  • 50. How to avoid complications when treating hyperdynamic folds and wrinkles.
    Sommer B
    Clin Dermatol; 2003; 21(6):521-3. PubMed ID: 14759586
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Asymmetrical smiles corrected by botulinum toxin serotype A.
    Benedetto AV
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S32-6. PubMed ID: 17241412
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Safe botulinum toxin type A injection in patients with history of eyelid ptosis.
    Ghalamkarpour F; Aghazadeh Y; Odabaei G
    J Cosmet Dermatol; 2009 Jun; 8(2):98-102. PubMed ID: 19527332
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Botulinum toxin for rejuvenation of the neck.
    Brandt FS; Boker A
    Clin Dermatol; 2003; 21(6):513-20. PubMed ID: 14759585
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Botulinum toxin type A (Botox) for the neuromuscular correction of excessive gingival display on smiling (gummy smile).
    Polo M
    Am J Orthod Dentofacial Orthop; 2008 Feb; 133(2):195-203. PubMed ID: 18249285
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Improvement in quality of life after botulinum toxin-A injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial.
    Sahai A; Dowson C; Khan MS; Dasgupta P
    BJU Int; 2009 Jun; 103(11):1509-15. PubMed ID: 19389019
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A multicenter, randomized, double-blind, placebo-controlled study of efficacy and safety of 3 doses of botulinum toxin A in the treatment of glabellar lines.
    Ascher B; Zakine B; Kestemont P; Baspeyras M; Bougara A; Santini J
    J Am Acad Dermatol; 2004 Aug; 51(2):223-33. PubMed ID: 15280841
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Combination therapy with BOTOX and fillers: the new rejuvnation paradigm.
    Coleman KR; Carruthers J
    Dermatol Ther; 2006; 19(3):177-88. PubMed ID: 16784517
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A randomized, evaluator-blinded, two-center study of the safety and effect of volume on the diffusion and efficacy of botulinum toxin type A in the treatment of lateral orbital rhytides.
    Carruthers A; Bogle M; Carruthers JD; Dover JS; Arndt KA; Hsu TS; Poirier J
    Dermatol Surg; 2007 May; 33(5):567-71. PubMed ID: 17451579
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A randomised, double-blind, dose-ranging study to evaluate efficacy and safety of three doses of botulinum toxin type A (Botox) for the treatment of spastic foot.
    Mancini F; Sandrini G; Moglia A; Nappi G; Pacchetti C
    Neurol Sci; 2005 Apr; 26(1):26-31. PubMed ID: 15877184
    [TBL] [Abstract][Full Text] [Related]  

  • 60. New procedures in facial plastic surgery using botulinum toxin A.
    Stupak HD; Maas CS
    Facial Plast Surg Clin North Am; 2003 Nov; 11(4):515-20. PubMed ID: 15062256
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.